Transgene expression by a large fraction of dendritic cells following autologous transplantation of retrovirally transduced CD34 cells.
Transgene expression by a large fraction of dendritic cells following autologous transplantation of retrovirally transduced CD34 cells.
复制标题
逆转录病毒转导的 CD34+ 细胞自体移植后,大部分树突状细胞进行转基因表达。
DOI:
10.1089/scd.2006.15.619
复制
发表时间:
2006
影响因子:
4
通讯作者:
Kiem,Hans-Peter
中科院分区:
文献类型:
--
作者:
Storek,Jan;Kiem,Hans-Peter
DENDRITIC CELLS (DCs) play a crucial role in immune responses to infectious microorganisms and cancer cells (1, 2). They are also essential for maintaining peripheral tolerance to self-antigens (3, 4). Both functions are mediated through antigen capture and processing and surface expression of fragments of the antigen (bound to the major histocompatibility complex). If the antigen fragments on the DC surface are coexpressed with costimulatory molecules like CD40 or CD86, T cells become stimulated. If not or if the DC secretes tryptophan metabolites, T cells may be rendered anergic or deleted (5, 6). Genetically engineered DCs may be used therapeutically in the future either to stimulate immunity (if engineered to express microbial or cancer antigens and costimulatory molecules)(7) or inhibit autoimmunity (if engineered to express autoantigens and to either not express costimulatory molecules or produce tryptophan metabolites). Here we present an observation that engineered DCs (expressing a transgene) are efficiently generated in vivo from CD34 cells carrying the transgene. Six juvenile baboons were irradiated (10.2 Gy) and infused with autologous CD34 cells as described (8, 9). The CD34 cells were transduced with a Phoenix Gibbon Ape Leukemia Virus-pseudotyped oncoretrovirus carrying the MNDMFGeYFP transgene (MNDMFG promoter and enhanced yellow fluorescent protein gene) as described (10). Thirty-nine to 70% of the infused CD34 cells expressed YFP (thus carried the transgene). Posttransplant, the percentage of YFP+ cells was determined by flow cytometry among circulating granulocytes (side scatter-high cells), CD4 T cells [CD3+ CD4+ CD8 J mononuclear cells (MNCs) by forward and side scatter], CD8 T cells (CD3+ CD4 J CD8+ MNCs), B cells (CD20+ MNCs), monocytes (CD14+ MNCs), natural killer (NK) cells